Jayne S. Danska

Last updated

Jayne S. Danska is an immunologist in Canada. Danska is a Senior Scientist at the Hospital for Sick Children, a Professor at the University of Toronto's Faculty of Medicine, and the Anne and Max Tanenbaum Chair in Molecular Medicine. [1] [2] [3]

Contents

Research

Danska holds a PhD in Genetics and Molecular Biology from Cornell University. [4] Her lab's research involves using both animal models and humans to investigate the mechanisms underlying immune system diseases (such as Type 1 diabetes), and improve diagnosis, prevention and treatment. [5] Danska is also one of the 14 researchers involved in the Integrated Microbiome Platforms for Advancing Causation Testing and Translation (IMPACTT), a pan-Canadian cross-disciplinary group conducting microbiome research. [6]

Previously, Danska's research found that in children with acute lymphoblastic leukemia, at the time of diagnosis, subpopulations of leukemic cells can cause a relapse. Additionally, in collaboration with John Dick, research from Danska's lab has previously led to the discovery of a gene (SIRPalpha) which can both support and destroy the growth of human blood stem cells, and was used to enable the successful grafting of stem cells from human bone marrow into mice. [5] [7] Ultimately, the researchers aim to develop a therapy to allow more children with blood diseases to receive life-saving bone marrow transplants. [5]

In 2022, Danska was selected as one of Canada's Most Powerful Women: Top 100. [8] She has spoken about different aspects of the COVID-19 pandemic, including the BA.4 And BA.5 SARS-CoV-2 variants, and the expected changes in menstruation after taking a COVID-19 vaccine. [2] [9]

Danska has published over 140 academic papers, which have been collectively cited over 8,000 times. [10]

Selected academic publications

Related Research Articles

<span class="mw-page-title-main">Stem cell</span> Undifferentiated biological cells that can differentiate into specialized cells

In multicellular organisms, stem cells are undifferentiated or partially differentiated cells that can change into various types of cells and proliferate indefinitely to produce more of the same stem cell. They are the earliest type of cell in a cell lineage. They are found in both embryonic and adult organisms, but they have slightly different properties in each. They are usually distinguished from progenitor cells, which cannot divide indefinitely, and precursor or blast cells, which are usually committed to differentiating into one cell type.

<span class="mw-page-title-main">Bone marrow</span> Semi-solid tissue in the spongy portions of bones

Bone marrow is a semi-solid tissue found within the spongy portions of bones. In birds and mammals, bone marrow is the primary site of new blood cell production. It is composed of hematopoietic cells, marrow adipose tissue, and supportive stromal cells. In adult humans, bone marrow is primarily located in the ribs, vertebrae, sternum, and bones of the pelvis. Bone marrow comprises approximately 5% of total body mass in healthy adult humans, such that a man weighing 73 kg (161 lbs) will have around 3.7 kg (8 lbs) of bone marrow.

<span class="mw-page-title-main">Hematopoietic stem cell transplantation</span> Medical procedure to replace blood or immune stem cells

Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood in order to replicate inside of a patient and to produce additional normal blood cells. It may be autologous, allogeneic or syngeneic.

<span class="mw-page-title-main">E. Donnall Thomas</span> American hematologist

Edward Donnall "Don" Thomas was an American physician, professor emeritus at the University of Washington, and director emeritus of the clinical research division at the Fred Hutchinson Cancer Research Center. In 1990 he shared the Nobel Prize in Physiology or Medicine with Joseph E. Murray for the development of cell and organ transplantation. Thomas and his wife and research partner Dottie Thomas developed bone marrow transplantation as a treatment for leukemia.

<span class="mw-page-title-main">CD34</span> Cluster of differentiation protocol that identifies cell surface antigens.

CD34 is a transmembrane phosphoglycoprotein protein encoded by the CD34 gene in humans, mice, rats and other species.

<span class="mw-page-title-main">Regenerative medicine</span> Field of medicine involved in regenerating tissues

Regenerative medicine deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function". This field holds the promise of engineering damaged tissues and organs by stimulating the body's own repair mechanisms to functionally heal previously irreparable tissues or organs.

<span class="mw-page-title-main">Cell therapy</span> Therapy in which cellular material is injected into a patient

Cell therapy is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

Cord blood is blood that remains in the placenta and in the attached umbilical cord after childbirth. Cord blood is collected because it contains stem cells, which can be used to treat hematopoietic and genetic disorders such as cancer. There is growing interest from cell therapeutics companies in developing genetically modified allogenic natural killer cells from umbilical cord blood as an alternative to CAR T cell therapies for rare diseases.

<span class="mw-page-title-main">Ernest McCulloch</span> Canadian cellular biologist (1926–2011)

Ernest Armstrong McCulloch was a University of Toronto cellular biologist, best known for demonstrating – with James Till – the existence of stem cells.

<span class="mw-page-title-main">Canadian Institutes of Health Research</span> Canadian federal agency

The Canadian Institutes of Health Research is a federal agency responsible for funding health and medical research in Canada. Comprising 13 institutes, it is the successor to the Medical Research Council of Canada.

<span class="mw-page-title-main">Adult stem cell</span> Multipotent stem cell in the adult body

Adult stem cells are undifferentiated cells, found throughout the body after development, that multiply by cell division to replenish dying cells and regenerate damaged tissues. Also known as somatic stem cells, they can be found in juvenile, adult animals, and humans, unlike embryonic stem cells.

Stem-cell therapy uses stem cells to treat or prevent a disease or condition. As of 2016, the only established therapy using stem cells is hematopoietic stem cell transplantation. This usually takes the form of a bone marrow transplantation, but the cells can also be derived from umbilical cord blood. Research is underway to develop various sources for stem cells as well as to apply stem-cell treatments for neurodegenerative diseases and conditions such as diabetes and heart disease.

<span class="mw-page-title-main">John Edgar Dick</span> Canadian cancer researcher

John Edgar Dick is Canada Research Chair in Stem Cell Biology, Senior Scientist at the Princess Margaret Cancer Centre, University Health Network and Professor in the Department of Molecular Genetics at the University of Toronto in Canada. Dick is credited with first identifying cancer stem cells in certain types of human leukemia. His revolutionary findings highlighted the importance of understanding that not all cancer cells are the same and thus spawned a new direction in cancer research. Dick is also known for his demonstration of a blood stem cell's ability to replenish the blood system of a mouse, his development of a technique to enable an immune-deficient mouse to carry and produce human blood, and his creation of the world's first mouse with human leukemia.

<span class="mw-page-title-main">Children's Hospital Oakland Research Institute</span>

Children's Hospital Oakland Research Institute (CHORI) is a biomedical research institute affiliated with California’s pediatric medical center, UCSF Benioff Children's Hospital Oakland.

<span class="mw-page-title-main">Robert Peter Gale</span> American physician and medical researcher

Robert Peter Gale is an American physician and medical researcher. He is known for research in leukemia and other bone marrow disorders.

Allen Charles Edward Eaves is the founding Director of the Terry Fox Laboratory for Hematology/Oncology Research, which over a 25-year period (1981–2006) he grew into an internationally recognized centre for the study of leukemia and stem cell research. His own research on chronic myelogenous leukemia (CML) has led the way to a new understanding of the disease. As Head of Hematology at the British Columbia Cancer Agency and the University of British Columbia for 18 years (1985–2003) he engineered the building of one of the first and largest bone marrow transplant programs in Canada. In recognition of his research accomplishments and leadership in moving basic science discoveries in stem cell biology into the clinic, he was elected President of the International Society of Cellular Therapy (1995–1997), Treasurer of the Foundation for the Accreditation of Cellular Therapy (1995–2002) and President of the American Society of Blood and Marrow Transplantation (1999–2000). In 2003 he was awarded the prestigious R. M. Taylor Medal by the Canadian Cancer Society and the National Cancer Institute of Canada.

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is a cancer treatment, research and education institution with six locations in the St. Louis area. Siteman is the only cancer center in Missouri and within 240 miles of St. Louis to be designated a Comprehensive Cancer Center by the National Cancer Institute (NCI). Siteman is also the only area member of the National Comprehensive Cancer Network, a nonprofit alliance of 32 cancer centers dedicated to improving the quality and effectiveness of cancer care.

Deng Hongkui is a Chinese immunologist and stem cell researcher. He is a Changjiang Professor, the Boya Chair Professor, and Director of the Institute of Stem Cell Research at Peking University. He was awarded US$1.9 million by the Bill & Melinda Gates Foundation for his research on vaccines for HIV and hepatitis C. In 2017, he and Chen Hu engineered resistance to HIV in mice using CRISPR gene editing, and for the first time used the technique on an AIDS patient.

<span class="mw-page-title-main">COH04S1</span> Vaccine candidate against COVID-19

COH04S1 is a covid vaccine developed by the City of Hope Medical Center. This vaccine targets patients who are immunocompromised; immunocompromised patients have often shown a weak antibody response to past COVID-19 vaccines. COH04S1 is also targeted on people who are at a high risk of COVID-19 complications. The City of Hope Medical Center strives to make a better option than the current EUA and FDA approved vaccines, which are not working as well on this group of individuals.

References

  1. Government of Canada, Canadian Institutes of Health Research (January 11, 2013). "Biographies: College Chairs - CIHR". cihr-irsc.gc.ca. Retrieved October 20, 2022.
  2. 1 2 Khaja, Mariyam (July 19, 2022). "Two Experts On How To Protect Yourself From BA.4 And BA.5". Chatelaine .
  3. "Jayne Danska". medbio.utoronto.ca. Retrieved October 20, 2022.
  4. "Jayne Danska | SickKids Directory". SickKids. Retrieved October 20, 2022.
  5. 1 2 3 "Sponsored | The people behind the breakthroughs". thestar.com. March 20, 2008. Retrieved October 20, 2022.
  6. "University of Calgary to lead pan-Canadian microbiome research core". News. February 11, 2019. Retrieved October 20, 2022.
  7. "Step forward in stem cell transplant research". CTVNews. November 5, 2007. Retrieved October 20, 2022.
  8. "Top 100 Award Winners 2022 - WXN".
  9. Taylor, Brooke (April 16, 2021). "Menstrual changes to be expected after COVID-19 vaccine, during pandemic: experts". Coronavirus. Retrieved October 20, 2022.
  10. "Jayne Danska". scholar.google.ca. Retrieved October 20, 2022.